NCT00240136 Long-term Observation of Patients With Early Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT00236678 Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT Status TERMINATED Phase PHASE2
NCT00236028 A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate Status COMPLETED Phase PHASE3
NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00234234 Predictors of the Response to Adalimumab in Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00233571 A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00233558 Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis Status TERMINATED Phase PHASE4
NCT00224562 The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists Status UNKNOWN Phase N/A
NCT00221000 Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00216177 Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis Status UNKNOWN Phase PHASE4
NCT00213564 Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT00213538 Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT00209859 Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis Status COMPLETED Phase PHASE4